GO analysis, conducted across three categories (cellular component [CC], biological process [BP], and molecular function [MF]), further confirmed the enrichment of DEGs in anti‐tumor immune‐related pathways, including the JAK‐STAT pathway and CD86 synthesis (Figure 5D–F). This evidence concerns the gene CD86 and neoplasm.